3 Results for "

PI3K/mTOR Inhibitor-11

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PI3K/mTOR Inhibitor-11" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-151622
CAS No.: 2845104-25-6
Purity:  98.74%
Target:  

PI3K mTOR

Research Areas:  

Cancer

PI3K/mTOR Inhibitor-11 is an orally active PI3K/mTOR inhibitor (IC50: 3.5, 4.6, and 21.3 nM for PI3Kα, PI3Kδ, and mTOR). PI3K/mTOR Inhibitor-11 regulates the PI3K/AKT/mTOR signaling pathway by inhibiting the phosphorylation of AKT and S6 proteins. PI3K/mTOR Inhibitor-11 can be used in the research of cancers .
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-124719
CAS No.: 1402452-15-6
Purity:  99.82%
Target:  

PI3K mTOR GSK-3 CDK

Research Areas:  

Cancer

hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1, with an IC50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-124760
CAS No.: 1402452-10-1
Purity:  99.94%
Target:  

mTOR PI3K CDK

Research Areas:  

Cancer

hSMG-1 inhibitor 11e is a potent and selective hSMG-1 kinase inhibitor with an IC50 of <0.05 nM. hSMG-1 inhibitor 11e shows >900-fold selectivity over mTOR (IC50 of 45 nM), PI3Kα/γ (IC50s of 61 nM and 92 nM) and CDK1/CDK2 (IC50s of 32 μM and 7.1 μM) .
loading...
    loading...